Fig. 3From: Real-world effectiveness, satisfaction, and optimization of ubrogepant for the acute treatment of migraine in combination with onabotulinumtoxinA: results from the COURAGE StudyAchievement of meaningful pain relief and return to normal function across up to 10 treated attacks in respondents who used ubrogepant and onabotulinumtoxinABack to article page